Skip to main content
. 2020 Jun 9;14:2207–2219. doi: 10.2147/DDDT.S247958

Figure 2.

Figure 2

Histopathological changes of gastric mucosa following administration of N‐methyl‐Nʹ‐nitro‐N‐nitrosoguanidine (MNNG) for 8, 12 and 16 weeks. (A and E) Histopathological changes of gastric mucosa in the control group (H&E staining, 10×, 40×). (B and F) Histopathological changes of gastric mucosa in the 8th week (H&E staining, 10×, 40×). (C and G) Histopathological changes of gastric mucosa in the 12th week (H&E staining, 10×, 40×). (D and H) Histopathological changes of gastric mucosa in the 16th week (H&E staining, 10×, 40×).